AngioDynamics Inc
NASDAQ:ANGO
Net Margin
AngioDynamics Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
AngioDynamics Inc
NASDAQ:ANGO
|
403.9m USD |
-78%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
219.3B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
181.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
150.8B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.3B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.2B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.1B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.6B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
41.8B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
293.4B CNY |
33%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37B USD |
10%
|
AngioDynamics Inc
Glance View
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on AngioDynamics Inc's most recent financial statements, the company has Net Margin of -78.4%.
You don't have any saved screeners yet